The Valley Desk

ArticleNeuro-oncology advancesPublished

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Neuro-oncology advances
Published
Subject terms
Angiogenesis; Glioblastoma; Vascular Endothelial Growth Factor; Cediranib
PubMed ID
38024244
PubMed Central ID
PMC10660192
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal